Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior

NeuroToxicology

Volumn 23, Issue 3, 2002, Pages 313-327

  Cory Slechta, Deborah A ^a   Brockel, B J ^a   O'Mara, D J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Dopamine; Fixed interval schedule controlled behavior; Lead; Nucleus accumbens; Rate dependency; Striatum

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; DOPAMINE; LEAD;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING KINETICS; BINDING SITE; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ENVIRONMENTAL EXPOSURE; EVOKED RESPONSE; HISTOLOGY; LEAD BLOOD LEVEL; MALE; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; WEANING;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DIMETHYL SULFOXIDE; DOPAMINE; DOPAMINE ANTAGONISTS; LEAD; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NEOSTRIATUM; QUINOLINES; RATS; RATS, LONG-EVANS; REINFORCEMENT SCHEDULE;

ANIMALIA;

EID: 0036744126     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00059-1     Document Type: Article

References (44)

1. Beckstead RM. Convergent thalamic and mesencephalic projections to the anterior medial cortex in the rat. J Comp Neurol 1976;166:403-16.
2. Bellinger D, Leviton A, Needleman HL, Waternaux C, Rabinowitz M. Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol 1986;8:151-61.
3. Bevins RA, Klebaur JE, Bardo MT. Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats. Behav Pharmacol 1997;8:113-23.
4. Bjorklund A, Lindvall O. Dopamine-containing systems in the CNS. In: Handbook of chemical neuroanatomy: classical transmitters in the CNS (part 1), vol. 2. Amsterdam: Elsevier, 1984. p. 55-122.
5. Cory-Slechta DA. The behavioral toxicity of lead: problems perspectives. In: Thompson T, Dews PB, Barrett JE, editors. Advances in behavioral pharmacology, vol. 4. New York: Academic Press, 1984. p. 211-55.
6. Cory-Slechta DA. Exposure duration modifies the effects of low level lead on fixed-interval performance. Neurotoxicology 1990;11:427-42.
7. Cory-Slechta DA. The role of dopaminergic and glutamatergic neurotransmitter systems in lead-induced learning impairments. In: Chang LW, Dyer R, editors. Neurotoxicology: effects and mechanisms. New York: Marcel Dekker, 1993.
8. Cory-Slechta DA. Implications of changes in schedule-controlled operant behavior. In: Weiss B, O'Donoghue J, editors. Neurobehavioral toxicity: analysis and interpretation. New York: Raven Press, 1994. p. 195-212.
9. Cory-Slechta DA, Weiss B. Alterations in schedule-controlled behavior of rodents correlated with prolonged lead exposure. In: Seiden LS, Balster RL, editors. Behavioral pharmacology: the current status. New York: Alan R. Liss, 1985. p. 487-501.
10. Cory-Slechta DA, Weiss B, Cox C. Performance and exposure indices of rats exposed to low concentrations of lead. Toxicol Appl Pharmacol 1985;78:291-9.
11. Cory-Slechta DA, Weiss B, Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethlenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther 1987;243:804-13.
12. Cory-Slechta DA, Pazmino R, Bare C. The critical role of the nucleus accumbens dopamine systems in the mediation of fixed interval schedule-controlled operant behavior. Brain Res 1997;764:253-6.
13. Cory-Slechta DA, O'Mara DJ, Brockel BJ. Nucleus accumbens dopaminergic mediation of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure. J Pharmacol Exp Ther 1998;286:794-805.
14. Darcheville JC, Riviere V, Wearden JH. Fixed-interval performance and self-control in children. J Exp Anal Behav 1992;57:187-99.
15. Darcheville JC, Riviere V, Wearden JH. Fixed-interval performance and self-control in infants. J Exp Anal Behav 1993;60:239-54.
16. Divac I, Markowitsch HJ, Pritzel M. Behavioral and anatomical consequences of small intra-striatal injections of kainic acid in the rat. Brain Res 1978;151:523-32.
17. Dunnett SB, Iversen SD. Learning impairments following selective kainic acid-induced lesions within the neostriatum of rats. Behav Brain Res 1981;2:189-209.
18. Fukuchi I, Fujita N, Nakahiro M, Saito K, Yoshida H. D2 dopamine receptors synthesis and turnover in rat striatum. Eur J Pharmacol 1986;127:291-4.
19. Giorgi O, Biggio G. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Brain Res 1990a;533:53-9.
20. Giorgi O, Biggio G. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions. Pharmacol Biochem Behav 1990b;35:877-84.
21. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998;279:1100-7.
22. Govoni S, Memo M, Spano PF, Trabucchi M. Chronic lead treatment differentially affects dopamine synthesis in various rat brain areas. Toxicology 1979;12:343-9.
23. Govoni S, Lucchi L, Missale C, Memo M, Spano SP, Trabucchi M. Effect of lead exposure on dopaminergic receptor in rat striatum and nucleus accumbens. Brain Res 1986;381:138-42.
24. Kelley AE, Domesick VB. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde- and retrograde-horseradish peroxidase study. Neuroscience 1982;7:2321-35.
25. Kirby RJ. Caudate nucleus lesions and perseverative behavior. Physiol Behav 1969;4:451-4.
26. Kula NS, George T, Baldessarini RJ. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ). Dev Brain Res 1992;66:286-9.
27. Marinelli M, White FJ. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 2000;20:8876-85.
28. McGeorge AJ, Faull RLM. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 1989;29:503-37.
29. Memo M, Lucchi L, Spano PF, Trabucchi M. Dose-dependent and reversible effects of lead on rat dopaminergic system. Life Sci 1981;28:795-9.
30. Missale C, Battaini F, Govoni S, Castelletti L, Spano PF, Trabucchi M. Chronic lead exposure differentially affects dopamine transport in striatum and nucleus accumbens. Toxicology 1984a;33:81-90.
31. Missale C, Battaini F, Govoni S, Castelletti L, Spano PF, Trabucchi M. Lead neurotoxicity: a role for dopamine receptors. Toxicology 1984b;33:81-90.
32. Moresco RM, Dall'olio R, Gandolfi O, Govoni S, DiGiovine S, Trabucchi M. Lead neurotoxicity: a role for dopamine receptors. Toxicology 1988;53:315-22.
33. Nowak G, Arnt J, Hyttel J. EEDQ, a tool for ex vivo measurement of occupancy of D1 and D2 dopamine receptors. Eur J Pharmacol 1988;153:309-11.
34. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press, 1986.
35. Pellegrino LJ, Pellegrino A, Cushman AJ. A stereotaxic atlas of the rat brain. New York: Plenum Press, 1979.
36. Piazza PV, Deminiere J-M, LeMoal M, Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989;245:1511-3.
37. Pisa M, Cyr J. Regionally selective roles of the rat's striatum in modality-specific discrimination learning and forelimb reaching. Behav Brain Res 1990;37:281-92.
38. Pokora MJ, Richfield EK, Cory-Slechta DA. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. J Neurochem 1996;67:1540-50.
39. Schwartzbaum JS, Donovick PJ. Discrimination reversal and spatial alternation associated with septal and caudate dysfunction in rats. J Comp Physiol Psychol 1968;65:83-92.
40. Siegel S. Non-parametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956.
41. Sills TL, Baird JP, Vaccarino FJ. Individual differences in the feeding effects of amphetamine: role of nucleus accumbens dopamine and circadian factors. Psychopharmacology 1993;112:211-8.
42. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351:429-33.
43. Widzowski DV, Finkelstein JN, Pokora MJ, Cory-Slechta DA. Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity. Neurotoxicology 1994;15:853-65.
44. Zuch CL, O'Mara DJ, Cory-Slechta DA. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: An in vivo electrochemistry time course study. Toxicol Appl Pharmacol 1998;150:174-85.